Adapting Project UPLIFT for Hispanic Patients With Epilepsy II
Adapting Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is for Hispanic Patients With Epilepsy II
1 other identifier
interventional
72
1 country
1
Brief Summary
The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding. The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 20, 2016
CompletedFirst Posted
Study publicly available on registry
December 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedMay 21, 2020
May 1, 2020
2.9 years
December 20, 2016
May 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Health Questionnaire (PHQ-9)
This measure assesses depressive symptoms in the past two weeks based on DSM-IV diagnostic criteria for major depression.
12 Months
Secondary Outcomes (2)
Quality Of Life in Epilepsy (QOLIE-10)
12 Months
PROMIS-Global
12 Months
Other Outcomes (10)
Work Productivity and Activity Impairment Questionnaire (WPAI)
12 Months
Self-Compassion Scale (SCS)
12 Months
Satisfaction with Life Scale (SWLS)
12 Months
- +7 more other outcomes
Study Arms (2)
UPLIFT
ACTIVE COMPARATORProject UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL).
USUAL CARE
ACTIVE COMPARATORParticipants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.
Interventions
Description of the UPLIFT program: Participants who choose to participate in UPLIFT will complete 8 weekly group sessions via telephone. Session 1: Introduction to UPLIFT/Noticing Thoughts Session 2: Checking and Changing Thoughts Session 3: Coping \& Relaxing Session 4: Attention \& Mindfulness Session 5: The Present as a Calm Place Session 6: Thoughts as Changeable, Thoughts as Not Fixed Session 7: Focus on Pleasure \& the Importance of Reinforcement Session 8: Preventing Lapses and Giving Thanks
Participants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.
Eligibility Criteria
You may qualify if:
- self-identified as Hispanic
- English or Spanish speaking
- diagnosis of epilepsy for at least one year post diagnosis
- willing to participate in 8 one-hour telephone sessions every week for eight weeks.
- willing to be audio-taped
- Elevated depressive symptoms (Center for Epidemiological Studies Depression Scale (CES-D) score \>13
You may not qualify if:
- Severe depression (CES-D \> 37)
- Active suicidal ideation
- Significant cognitive impairment (evident during screening)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tanya Spruill
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2016
First Posted
December 22, 2016
Study Start
October 1, 2016
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
May 21, 2020
Record last verified: 2020-05